Peer review reports
From: Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma
Original Submission |
7 Aug 2021 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
29 Oct 2021 |
Reviewed |
Reviewer Report
|
10 Nov 2021 |
Reviewed |
Reviewer Report
|
10 Dec 2021 |
Author responded |
Author comments - Wei Jia
|
Resubmission - Version 3 |
10 Dec 2021 |
Submitted |
Manuscript version 3
|
Publishing |
20 Dec 2021 |
Editorially accepted |
|
13 Jan 2022 |
Article published |
10.1186/s12864-021-08265-y
|
Learn about peer review